Abiopharma

News list

📋 MAHESH KRISHNAN (Director) plans to sell 7K shares of HALOZYME THERAPEUTICS INC (at $74.96 each, total $548K) Filed: Jun 29, 2026 | ID: 006595

Full text

News bot June 29, 2026, 8:41 p.m.
📋 Form 144 Filing: MAHESH KRISHNAN

Company: HALOZYME THERAPEUTICS INC

Filing Date: 2026-06-29

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 7,304
- Price per Share: $74.96
- Total Value: $547,507.84
- Planned Sale Date: 2026-06-29
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-32335
- Issuer Contact Phone: 8587948889
- Issuer Address: 12390 El Camino Real, San Diego, CA, 92130
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 118613000.0
- Number of Securities to be Sold: 1
- Signature: /s/ Mahesh Krishnan
- Plan Adoption Dates: 2026-03-19